Gene · 715
Papers2,917
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,041 to 1,060 of 2,917
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immunological Basis of the Endometriosis: The Complement System as a Potential Therapeutic Target. | Front Immunol | 2020 | 33505394 | PubTator, text mining | PubMed |
| Proteomic analysis of platelet-rich and platelet-poor plasma. | Regen Ther | 2020 | 33426223 | PubTator, text mining | PubMed |
| Proteomics of Muscle Microdialysates Identifies Potential Circulating Biomarkers in Facioscapulohumeral Muscular Dystrophy. | Int J Mol Sci | 2020 | 33396627 | PubTator, text mining | PubMed |
| Initiators of Classical and Lectin Complement Pathways Are Differently Engaged after Traumatic Brain Injury-Time-Dependent Changes in the Cortex, Striatum, Thalamus and Hippocampus in a Mouse Model. | Int J Mol Sci | 2020 | 33375205 | PubTator, text mining | PubMed |
| Crouching Tiger, Hidden Protein: Searching for Insecticidal Toxins in Venom of the Red Tiger Assassin Bug (Havinthus rufovarius). | Toxins (Basel) | 2020 | 33375154 | PubTator, text mining | PubMed |
| Moieties of Complement iC3b Recognized by the I-domain of Integrin αXβ2. | Mol Cells | 2020 | 33372665 | PubTator, text mining | PubMed |
| T-cell responses to sequentially emerging viral escape mutants shape long-term HIV-1 population dynamics. | PLoS Pathog | 2020 | 33370400 | PubTator, text mining | PubMed |
| Complement Inhibition for the Treatment of Myasthenia Gravis. | Immunotargets Ther | 2020 | 33365280 | PubTator, text mining | PubMed |
| Treatment of Rare Inflammatory Kidney Diseases: Drugs Targeting the Terminal Complement Pathway. | Front Immunol | 2020 | 33362783 | PubTator, text mining | PubMed |
| Therapeutic Lessons to be Learned From the Role of Complement Regulators as Double-Edged Sword in Health and Disease. | Front Immunol | 2020 | 33362763 | PubTator, text mining | PubMed |
| Insights Into the Proteomic Profiling of Extracellular Vesicles for the Identification of Early Biomarkers of Neurodegeneration. | Front Neurol | 2020 | 33362690 | PubTator, text mining | PubMed |
| Molecular Network Profiling in Intestinal- and Diffuse-Type Gastric Cancer. | Cancers (Basel) | 2020 | 33353109 | PubTator, text mining | PubMed |
| Insights Into Immunothrombosis: The Interplay Among Neutrophil Extracellular Trap, von Willebrand Factor, and ADAMTS13. | Front Immunol | 2020 | 33343584 | PubTator, text mining | PubMed |
| Identification of Potential Serum Protein Biomarkers and Pathways for Pancreatic Cancer Cachexia Using an Aptamer-Based Discovery Platform. | Cancers (Basel) | 2020 | 33334063 | PubTator, text mining | PubMed |
| Redox Regulator GLRX Is Associated With Tumor Immunity in Glioma. | Front Immunol | 2020 | 33329553 | PubTator, text mining | PubMed |
| Preparing for Life: Plasma Proteome Changes and Immune System Development During the First Week of Human Life. | Front Immunol | 2020 | 33329546 | PubTator, text mining | PubMed |
| Quantitative multiplex profiling of the complement system to diagnose complement-mediated diseases. | Clin Transl Immunology | 2020 | 33318796 | PubTator, text mining | PubMed |
| Thermostability profiling of MHC-bound peptides: a new dimension in immunopeptidomics and aid for immunotherapy design. | Nat Commun | 2020 | 33298915 | PubTator, text mining | PubMed |
| Identification of a 6-Gene Signature Associated with Resistance to Tyrosine Kinase Inhibitors: Prognosis for Clear Cell Renal Cell Carcinoma. | Med Sci Monit | 2020 | 33296352 | PubTator, text mining | PubMed |
| Autoimmune hemolytic anemia: current knowledge and perspectives. | Immun Ageing | 2020 | 33292368 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/715/papers?page=53